Ceftolozane-tazobactam versus levofloxacin in urinary tract infection - Authors' reply

The Lancet

Volumn 386, Issue 10000, 2015, Pages 1242-

  Wagenlehner, Florian M ^a   Umeh, Obiamiwe ^b   Darouiche, Rabih O ^c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b CUBIST PHARMACEUTICALS INC   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTOLOZANE PLUS TAZOBACTAM; ERTAPENEM; LEVOFLOXACIN; CEPHALOSPORIN DERIVATIVE; PENICILLANIC ACID; URINARY TRACT ANTIINFECTIVE AGENT;

ABDOMINAL INFECTION; ANTIMICROBIAL THERAPY; CLINICAL TRIAL (TOPIC); DISEASE SEVERITY; HUMAN; LETTER; PRIORITY JOURNAL; PYELONEPHRITIS; URINARY TRACT INFECTION; ANALOGS AND DERIVATIVES; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; MALE; URINARY TRACT INFECTIONS;

ANTI-INFECTIVE AGENTS, URINARY; CEPHALOSPORINS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LEVOFLOXACIN; MALE; PENICILLANIC ACID; URINARY TRACT INFECTIONS;

EID: 84943414068     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)00263-9     Document Type: Letter

References (3)

1. FM Wagenlehner, O Umeh, J Steenbergen, G Yuan, RO Darouiche Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECTcUTI) Lancet 385 2015 1949 1956
2. MJ Dinubile, I Friedland, CY Chan et al. Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy Eur J Clin Microbiol Infect Dis 24 2005 443 449
3. M Koningstein, AK van der Bij, MEA de Kraker et al. Recommendation for the empirical treatment of complicated urinary tract infections using surveillance data on antimicrobial resistance in the Netherlands PLoS One 9 2014 e86634